ArticleJournal of translational medicine2022

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC.

Carminia Maria Della Corte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.